1492 Capital Management »

Syndax Pharmaceuticals shares owned by 1492 Capital Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by 1492 Capital Management from 13F filings

Historical chart of 1492 Capital Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by 1492 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by 1492 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 67k 21.86

More positions owned by 1492 Capital Management

MaxLinear (MXL)
Carpenter Technology Corporation (CRS)
Alignment Healthcare (ALHC)
Applied Optoelectronics (AAOI)
Sterling Construction Company (STRL)
Copa Holdings Sa Cl A (CPA)
Adaptive Biotechnologies Cor (ADPT)
Allegheny Technologies Incorporated (ATI)
Adtran Holdings (ADTN)
Kaiser Aluminium Corporation Com Par $0.01 (KALU)
Lumentum Hldgs (LITE)
Zeta Global Holdings Corp Cl A (ZETA)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Axsome Therapeutics (AXSM)
Meritage Homes Corporation (MTH)

View all positions for 1492 Capital Management

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Deerfield Management Company
Eversept Partners
Geode Capital Management
Hood River Capital Management
Kingdon Capital Management
Franklin Resources
Millennium Management
Vanguard Portfolio Management
UBS Group

View all funds holding Syndax Pharmaceuticals